Global Heart Failure Academy

Leading global experts have combined guideline recommendations and new clinical data with practical, case-based formats that approximate clinical reality to improve patient outcomes in the management of heart failure. This series is focused on changing clinical behavior in the recognition and diagnoses of hyperkalemia and iron deficiency in heart failure, through the application of emerging science into everyday practice.
To return to the Global Heart Failure Academy, please click here.
This educational series is developed by Medtelligence. Supported by an unrestricted educational grant from CSL Vifor.
.png)
1-15 of 23

Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
MinuteCE®Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex

Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
MinuteCE®Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs

From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
MinuteCE®From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection

Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
MinuteCE®Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load

The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
MinuteCE®The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
- advertisement

Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
CME/CEEngaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy

Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
NephrologyOptimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines

Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
NephrologyIndividualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease

Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
CME/CEPractical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure

Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
CME/CECracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure

FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
CME/CEFAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
- advertisement

Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
CME/CEPearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD

Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
CME/CEBreaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy

Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
CME/CEPartnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management














































